•  
  •  
  •  
  •  

2023-01-29 22:30:26

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HFCL Ltd and HTL Ltd receive orders worth Rs. 206.67 crores
  • Krsnaa Diagnostics operationalizes 1 Diagnostic Center in UP
  • Indiabulls Enterprises Ltd consolidated Q3FY23 profit at Rs. 1.51 crore
  • Capri Global Capital Ltd Q3 FY2023 consolidated net profit slides to Rs. 37.41 crores
  • CARE Ratings Ltd reports consolidated PAT of Rs. 15.95 crores in Q3FY23

Keywords Selected:  Form483

Stock Report

  • USFDA inspection at Indoco Remedies Limited's Solid Oral Formulation Facility - Plant 1 at Goa
  • Aurobindo Pharma Ltd updates on USFDA inspection
  • Lupin gets 2 observations from USFDA for Somerset facility
  • Piramal Pharma Ltd gets 2 observations from USFDA for Sellersville facility
  • Piramal Pharma Ltd gets 6 observations from USFDA for Lexington facility
  • Alembic Pharmaceuticals gets 5 observations from USFDA for Solid Oral Formulation Facility (F-4) at Jarod
  • Lupin's Mandideep Unit-1 facility gets Form 483 from USFDA with 8 observations
  • Aurobindo Pharma Ltd receives 10 observations for Unit IX
  • US FDA Inspection of Lupin's Nagpur Unit-2 injectable manufacturing facility
  • Laurus Labs Ltd gets one observation from USFDA for Pre-Approval Inspection
  • USFDA inspects Alembic Pharmaceuticals' Oncology Injectable Formulation Facility at Panelav
  • US FDA inspection at Alkem's manufacturing facility located at St. Louis, USA
  • Ajanta Pharma Ltd gets Form 483 with 2 procedural observations for Dahej Formulation facility
  • USFDA inspection at Alembic Pharmaceuticals Injectable Facility (F-3) at Karkhadi
  • US FDA Inspection at Gland Pharma's Dundigal Facility, Hyderabad
  • Sun Pharmaceutical Industries Ltd Update on US FDA Inspection at Mohali Facility
  • Zydus Lifesciences Ltd gets 4 observations from USFDA for Moraiya facility
  • USFDA issues 3 observations for Aurobindo Pharma Ltd's Unit XI
  • US FDA Inspection at Alkem's manufacturing facility located at Indore
  • Cipla updates on US FDA product-specific Pre-Approval Inspection
  • USFDA issues Form 483 for Glenmark Pharmaceuticals Ltd's Aurangabad facility
  • U.S. FDA inspection at Glenmark Pharmaceuticals Ltd's Baddi, India Facility
  • Glenmark Pharma gets 5 observations from U.S. FDA for its Goa, India Facility
  • Sun Pharmaceutical Industries gets 10 observations from US FDA for Halol facility

Latest Post

  • HFCL Ltd and HTL Ltd receive orders worth Rs. 206.67 crores
  • Krsnaa Diagnostics operationalizes 1 Diagnostic Center in UP
  • Indiabulls Enterprises Ltd consolidated Q3FY23 profit at Rs. 1.51 crore
  • Capri Global Capital Ltd Q3 FY2023 consolidated net profit slides to Rs. 37.41 crores
  • CARE Ratings Ltd reports consolidated PAT of Rs. 15.95 crores in Q3FY23


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022